Promising immunotherapeutic targets for treating candidiasis.

Area of Science:

• Mycology
• Infectious Diseases
• Pharmacology

Background:

• Invasive fungal infections are increasing, particularly in immunocompromised individuals, leading to high mortality rates.
• Existing antifungal drugs (azoles, polyenes, echinocandins) exhibit limitations including resistance and adverse effects, highlighting the need for new treatments.

Purpose of the Study:

• To review the structure and function of key proteins in *Candida albicans* (cell wall, secreted, functional).
• To analyze current advancements and challenges in macromolecular antifungal drugs.
• To identify novel therapeutic targets for managing candidiasis.

Main Methods:

• Literature review focusing on *Candida albicans* protein structures and functions.
• Analysis of current research on macromolecular antifungal agents.
• Exploration of potential drug targets for antifungal therapies.

Main Results:

• Identified key protein targets within *C. albicans* for antifungal drug development.
• Highlighted the potential of vaccines and antibodies as targeted antifungal interventions.
• Assessed the limitations and opportunities in developing novel macromolecular antifungal drugs.

Conclusions:

• There is an urgent need for new antifungal therapies due to rising infections and drug resistance.
• Targeting specific proteins in *C. albicans* and developing macromolecular drugs offer promising strategies.
• Further research into vaccines, antibodies, and novel drug targets is crucial for effective candidiasis treatment.